Page 8 of 13 – SEC Filing
| CUSIP No. 481116101 | 13G | Page 8 of 13 Pages |
| Item 1(a) | Name of Issuer |
| Jounce Therapeutics, Inc. | |
| Item 1(b) | Address of Issuer’s Principal Executive Offices |
| 780 Memorial Drive, Cambridge, Massachusetts 02139 | |
| Item 2(a) | Name of Person Filing |
| This Schedule 13G is being jointly filed by Partner Fund Management, L.P. (“PFM”), Partner Fund Management GP, LLC (“PFM-GP”), Partner Investment Management, L.P. (“PIM”), Partner Investment Management GP, LLC (“PIM-GP”), Brian D. Grossman (“Grossman”) and Christopher M. James (“James” and, collectively with PFM, PFM-GP, PIM, PIM-GP and Grossman, the “Reporting Persons”) with respect to shares of common stock of the above-named issuer owned by PFM Healthcare Emerging Growth Master Fund, L.P., a Cayman Islands limited partnership (“HEGM”), PFM Healthcare Master Fund, L.P., a Cayman Islands limited partnership (“HCM”), PFM Healthcare Opportunities Master Fund, L.P., a Cayman Islands limited partnership (“HCOPP”), PFM Healthcare Long Master Fund, L.P., a Cayman Islands limited partnership (“HCLM”), PFM Oncology Opportunities Master Fund II, L.P., a Cayman Islands limited partnership (“HCONC”) and PFM Healthcare Principals Fund, L.P., a Delaware limited partnership (“HCP” and, collectively with HEGM, HCM, HCOPP, HCLM and HCONC, the “Funds”). | |
| PFM is the investment advisor for HEGM, HCM, HCOPP, HCLM and HCONC. PIM is the investment advisor for HCP. PFM-GP and PIM-GP are, respectively, the general partners of PFM and PIM. Grossman is the portfolio manager for the health care strategy for the Funds. James is the portfolio manager for the diversified strategy for the Funds. Grossman and James are co-managing members of PFM-GP and PIM-GP. | |
| The filing of this statement shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any securities covered by the statement other than the securities actually owned by such person (if any). | |
| Item 2(b) | Address of Principal Business Office |
| The address of the principal business office of each of the Reporting Persons is c/o Partner Fund Management, L.P., 4 Embarcadero Center, Suite 3500, San Francisco, CA 94111. | |
| Item 2(c) | Citizenship |
| Each of PFM and PIM is organized as a limited partnership under the laws of the State of Delaware. Each of PFM-GP and PIM-GP is organized as a limited liability company under the laws of the State of Delaware. Each of Grossman and James is a U.S. citizen. | |
| Item 2(d) | Title of Class of Securities |
| Common stock, $0.001 par value | |
| Item 2(e) | CUSIP Number |
| 481116101 |
Follow Jounce Therapeutics Inc. (NASDAQ:JNCE)
Follow Jounce Therapeutics Inc. (NASDAQ:JNCE)
Receive real-time insider trading and news alerts
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
